SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No.2)*
Medix Resources, Inc.
(Name of Issuer)
Common Stock
(Title Class of Securities)
585011 10 9
(CUSIP Number)
Lyle B. Stewart, Esq., Lyle B. Stewart, P.C.
3751 S. Quebec Street, Denver, Colorado 80237, (303) 267-0920
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
February 1, 2000
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
check the following box [ ].
The remainder of this cover page shall be filled out for a reporting
person's initial filing or initial EDGAR filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of section 18 of the Securities Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
<PAGE>
SCHEDULE 13D
CUSIP No. 585011 10 9
Page 2 of 5 Pages
(1) NAME OF REPORTING PERSON: JOHN PETER YEROS
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
a. __
b. __
(3) SEC USE ONLY:
(4) SOURCE OF FUNDS: PF
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e): [ ]
(6) CITIZENSHIP OR PLACE OF ORGANIZATION: U.S. Citizen
NUMBER OF SHARES BENEFICIAL OWNED BY REPORTING PERSON WITH:
(7) SOLE VOTING POWER: 3,289,768 shares, of which 3,159,768 shares are
deemed beneficially owned because the reporting person holds options and
other rights that would permit
him to acquire such shares within the next 60 days.
(8) SHARED VOTING POWER: 0
(9) SOLE DISPOSITIVE POWER: 3,289,768 shares, of which 3,159,768 shares
are deemed beneficially owned because the reporting person holds
options and other rights that would permit him to acquire such shares
within the next 60 days.
(10) SHARED DISPOSITIVE POWER: 0
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON:
3,289,768 shares, of which 3,159,768 shares are deemed beneficially
owned because the reporting person holds options and other rights that
would permit him to acquire such shares within the next 60 days.
<PAGE>
SCHEDULE 13D
CUSIP No 5850911 10 9
Page 3 of 5 Pages
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES: [ ]
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 9.2 % of
Issuer's outstanding Common Stock
(14) TYPE OF REPORTING PERSON: IN
Item 1. Security and Issuer.
This statement relates to shares of the Common Stock ("Common Stock"), par value
of $.001 per share, of Medix Resources, Inc., a Colorado corporation (the
"Issuer"). Beneficial ownership reported herein includes Common Stock issuable
upon the exercise of stock options and warrants issued to the reporting person
by the Issuer. The Issuer maintains its principal executive offices at 7100 E.
Belleview Ave., Suite 301, Englewood, CO 80111.
Item 2. Identity and Background.
(a) This statement is filed by John P. Yeros (the "Reporting
Person").
(b) His business address is 7100 E. Belleview Ave., Suite 301, Englewood, CO
80111.
(c) The principal occupation of the Reporting Person is Chairman of the Board
of the Issuer.
(d) During the last five years, the Reporting Person has not been convicted in
any criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) During the last five years, the Reporting Person has not been a party to
any civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which he was or is subject to a judgment,
decree, or final order enjoining future violations of , or prohibiting or
mandating activities subject to, federal or state securities laws or
finding any violation with respect to such laws.
(f) The Reporting Person is a citizen of the United States.
<PAGE>
SCHEDULE 13D
CUSIP No 5850911 10 9
Page 4 of 5 Pages
Item 3. Source and Amount of Funds or Other Consideration.
If the Reporting Person exercises any of the options and warrants that have been
granted to the
Reporting Person as part of his compensation by the Issuer, he will use personal
funds.
Item 4. Purpose of Transaction.
The Reporting Person has acquired and may acquire Common Stock from time to time
pursuant to outstanding options, convertible securities and warrants for
personal investment purposes. He may dispose of Common Stock from time to time
for personal financial reasons.
Item 5. Interest in Securities of the Issuer.
(a) See items (11) and (13) on pages 2 and 3 of this Schedule 13D.
(b) See items (7) through (10) on page 2 of this Schedule 13D.
(c)On December 9, 1999, the Reporting Person purchased from the Issuer 25
Units, each consisting of one share of 1999 Series C Convertible Preferred
Stock of the Issuer and Warrants to purchase 4,000 shares of Common Stock
at an exercise price of $0.50 per share. The purchase price of each Unit
was $1,000. Each share of the Issuer's 1999 Series C Convertible Preferred
Stock is convertible into 2,000 shares of the Issuer's Common Stock.
(d) None
(e) Not applicable
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.
None, other than standard stock purchase agreements, option agreements and
warrant agreements between the Issuer and the Reporting Person.
Item 7. Material Filed as Exhibits.
None
<PAGE>
SCHEDULE 13D
CUSIP No 5850911 10 9
Page 5 of 5 Pages
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 10, 2000
/s/John P. Yeros
-----------------
John P. Yeros
